2023 - Research.com Biology and Biochemistry in Japan Leader Award
His main research concerns Biochemistry, Internal medicine, Cell biology, Alzheimer's disease and Pathology. His study connects Molecular biology and Biochemistry. His Internal medicine research includes elements of Gastroenterology, Endocrinology, Surgery and Immunology.
His Endocrinology study combines topics in areas such as Vitamin E deficiency and Vitamin E. His Cell biology research incorporates elements of Autophagy and Unsaturated fatty acid. His Alzheimer's disease research is multidisciplinary, incorporating elements of Amyloid beta and Vascular dementia.
His primary scientific interests are in Biochemistry, Internal medicine, Pathology, Cell biology and Disease. His research on Biochemistry frequently links to adjacent areas such as Molecular biology. His studies deal with areas such as Gastroenterology and Endocrinology as well as Internal medicine.
His Alzheimer's disease, Cerebrospinal fluid, Tau protein, Dementia and Amyloid study are his primary interests in Pathology. His Alzheimer's disease study combines topics from a wide range of disciplines, such as Apolipoprotein E and Central nervous system disease, Degenerative disease.
Hiroyuki Arai focuses on Biochemistry, Cell biology, Internal medicine, Pathology and Alzheimer's disease. His study in Biochemistry concentrates on Enzyme, Polyunsaturated fatty acid, Fatty acid, Docosahexaenoic acid and Intracellular. His study in the fields of Endoplasmic reticulum, Golgi apparatus, Endosome and Transport protein under the domain of Cell biology overlaps with other disciplines such as Sting.
The study incorporates disciplines such as Endocrinology, Cognition and Cardiology in addition to Internal medicine. His work investigates the relationship between Pathology and topics such as Positron emission tomography that intersect with problems in Magnetic resonance imaging and Neuroimaging. His biological study deals with issues like Dementia, which deal with fields such as Cerebrospinal fluid.
His scientific interests lie mostly in Cell biology, Alzheimer's disease, Pathology, Biochemistry and Dementia. His study looks at the relationship between Cell biology and fields such as Membrane protein, as well as how they intersect with chemical problems. Hiroyuki Arai has included themes like Biomarker, Magnetic resonance imaging, Nuclear medicine and Cognitive decline in his Alzheimer's disease study.
His Pathology research is multidisciplinary, incorporating perspectives in White matter, Temporal cortex, Cerebral cortex, Globus pallidus and Positron emission tomography. His research on Biochemistry frequently connects to adjacent areas such as Apolipoprotein E. His Dementia research incorporates elements of Differential diagnosis, Physical therapy and Statistical significance.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium
I. G. McKeith;I. G. McKeith;D. W. Dickson;J. Lowe;M. Emre.
Neurology (2005)
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.
B. Winblad;K. Palmer;Miia Kivipelto;V. Jelic.
Journal of Internal Medicine (2004)
Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.
Makiko Umezu-Goto;Yasuhiro Kishi;Akitsu Taira;Kotaro Hama.
Journal of Cell Biology (2002)
Affinity for α‐tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs
Akihiro Hosomi;Makoto Arita;Yuji Sato;Chikako Kiyose.
FEBS Letters (1997)
Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease'
Peter Davies;Judith Resnick;Burton Resnick;Sid Gilman.
Neurobiology of Aging (1998)
Ataxia with isolated vitamin E deficiency is caused by mutations in the α–tocopherol transfer protein
Karim Ouahchi;Makoto Arita;Herbert Kayden;Fayçal Hentati.
Nature Genetics (1995)
Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARγ agonist
Thomas M. McIntyre;Aaron V. Pontsler;Adriana R. Silva;Andy St. Hilaire.
Proceedings of the National Academy of Sciences of the United States of America (2003)
LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing.
Xiaoqin Ye;Kotaro Hama;James J. A. Contos;Brigitte Anliker.
Nature (2005)
Molecular Cloning and Characterization of a Novel Human G-protein-coupled Receptor, EDG7, for Lysophosphatidic Acid
Koji Bandoh;Junken Aoki;Hiroyuki Hosono;Susumu Kobayashi.
Journal of Biological Chemistry (1999)
Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor
Mitsuharu Hattori;Hideki Adachi;Masafumi Tsujimoto;Hiroyuki Arai.
Nature (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Tohoku Medical and Pharmaceutical University
University of Tokyo
Tohoku University
Southwest University
Tohoku University
University of Tokyo
University of Tokyo
RIKEN
National Institutes for Quantum and Radiological Science and Technology
University of Pennsylvania
Yale University
University of Illinois at Urbana-Champaign
Victoria University
University of Kentucky
University of Basel
Fudan University
Beijing Institute of Technology
Iowa State University
Baystate Medical Center
Washington State University
Skidaway Institute of Oceanography
University of Alaska Fairbanks
The University of Texas at Arlington
University of Florida
New York University
Karolinska Institute